BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35926257)

  • 21. The Steroidogenic Enzyme AKR1C3 Regulates Stability of the Ubiquitin Ligase Siah2 in Prostate Cancer Cells.
    Fan L; Peng G; Hussain A; Fazli L; Guns E; Gleave M; Qi J
    J Biol Chem; 2015 Aug; 290(34):20865-20879. PubMed ID: 26160177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
    Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
    J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.
    Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T
    J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD166 positively regulates MCAM via inhibition to ubiquitin E3 ligases Smurf1 and βTrCP through PI3K/AKT and c-Raf/MEK/ERK signaling in Bel-7402 hepatocellular carcinoma cells.
    Tang X; Chen X; Xu Y; Qiao Y; Zhang X; Wang Y; Guan Y; Sun F; Wang J
    Cell Signal; 2015 Sep; 27(9):1694-702. PubMed ID: 26004137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
    He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
    Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
    Liu L; Wong CC; Gong B; Yu J
    Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway.
    Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J
    J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Regulatory Oncogenic or Tumor Suppressor miRNAs of PI3K/AKT Signaling Axis in the Pathogenesis of Colorectal Cancer.
    Soleimani A; Rahmani F; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
    Curr Pharm Des; 2018; 24(39):4605-4610. PubMed ID: 30636581
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Liu Y; Sun M; Zhang B; Zhao W
    Aging (Albany NY); 2023 Sep; 15(17):9182-9192. PubMed ID: 37708299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation.
    Buchwald M; Pietschmann K; Brand P; Günther A; Mahajan NP; Heinzel T; Krämer OH
    Oncogene; 2013 Oct; 32(41):4913-20. PubMed ID: 23208506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
    Tan M; Xu J; Siddiqui J; Feng F; Sun Y
    Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
    Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
    Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression.
    Liu Q; Luo Q; Feng J; Zhao Y; Ma B; Cheng H; Zhao T; Lei H; Mu C; Chen L; Meng Y; Zhang J; Long Y; Su J; Chen G; Li Y; Hu G; Liao X; Chen Q; Zhu Y
    Elife; 2022 Aug; 11():. PubMed ID: 35913115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitin-dependent regulation of phospho-AKT dynamics by the ubiquitin E3 ligase, NEDD4-1, in the insulin-like growth factor-1 response.
    Fan CD; Lum MA; Xu C; Black JD; Wang X
    J Biol Chem; 2013 Jan; 288(3):1674-84. PubMed ID: 23195959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-FU inhibits migration and invasion of CRC cells through PI3K/AKT pathway regulated by MARCH1.
    Wang N; Yang L; Dai J; Wu Y; Zhang R; Jia X; Liu C
    Cell Biol Int; 2021 Feb; 45(2):368-381. PubMed ID: 33085122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
    Feng Y; Qian W; Zhang Y; Peng W; Li J; Gu Q; Ji D; Zhang Z; Wang Q; Zhang D; Sun Y
    BMC Cancer; 2019 Jun; 19(1):576. PubMed ID: 31196027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway.
    Seo D; Jung SM; Park JS; Lee J; Ha J; Kim M; Park SH
    EBioMedicine; 2019 Nov; 49():55-71. PubMed ID: 31685442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways.
    Hu Z; Long T; Ma Y; Zhu J; Gao L; Zhong Y; Wang X; Wang X; Li Z
    J Exp Clin Cancer Res; 2020 May; 39(1):76. PubMed ID: 32370786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.